ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+14.09%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$730M
AUM Growth
+$730M
(+5.3%)
Cap. Flow
-$1.39M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
35
New
7
Increased
7
Reduced
6
Closed
12
Top Buys
| 1 |
Universal Health Services
UHS
|
$74.2M |
| 2 |
Exact Sciences
EXAS
|
$47M |
| 3 |
Boston Scientific
BSX
|
$46M |
| 4 |
United Therapeutics
UTHR
|
$44.2M |
| 5 |
Icon
ICLR
|
$40M |
Top Sells
| 1 |
Sanofi
SNY
|
$64.2M |
| 2 |
UnitedHealth
UNH
|
$37.8M |
| 3 |
Gilead Sciences
GILD
|
$34.8M |
| 4 |
Evolent Health
EVH
|
$32.5M |
| 5 |
Charles River Laboratories
CRL
|
$26.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Icon
ICLR
$13.8B
| $87.6M | 11.71% | 350,000 +160,000 | +84% | +$40M |
|
|
2
Universal Health Services
UHS
$11.6B
| $74.2M | 9.91% | +470,000 | New | +$74.2M |
|
3
AbbVie
ABBV
$372B
| $60.6M | 8.1% | 450,000 +130,000 | +41% | +$17.5M |
|
|
4
Exact Sciences
EXAS
$8.98B
| $47M | 6.28% | +500,000 | New | +$47M |
|
|
5
Boston Scientific
BSX
$156B
| $46M | 6.15% | +850,000 | New | +$46M |
|
|
6
United Therapeutics
UTHR
$13.8B
| $44.2M | 5.9% | +200,000 | New | +$44.2M |
|
7
Intuitive Surgical
ISRG
$170B
| $41M | 5.49% | 120,000 | – | – |
|
8
Acadia Healthcare
ACHC
$2.12B
| $40.1M | 5.36% | 503,447 -9,259 | -2% | -$737K |
|
9
Establishment Labs
ESTA
$1.2B
| $36.9M | 4.93% | 537,906 +112,906 | +27% | +$7.75M |
|
10
Pacific Biosciences
PACB
$393M
| $31.9M | 4.27% | 2,400,000 +100,000 | +4% | +$1.33M |
|
11
Cooper Companies
COO
$13.4B
| $28.8M | 3.84% | 75,000 -10,000 | -12% | -$3.83M |
|
12
Surgery Partners
SGRY
$2.91B
| $26.1M | 3.49% | 580,973 -234,579 | -29% | -$10.6M |
|
13
Align Technology
ALGN
$10.3B
| $23M | 3.07% | +65,000 | New | +$23M |
|
14
Inspire Medical Systems
INSP
$2.77B
| $22.7M | 3.04% | 70,000 | – | – |
|
15
Glaukos
GKOS
$5.5B
| $22.1M | 2.95% | +310,000 | New | +$22.1M |
|
16
10x Genomics
TXG
$1.74B
| $21.2M | 2.84% | 380,000 +30,000 | +9% | +$1.68M |
|
17
DexCom
DXCM
$29.5B
| $19.3M | 2.58% | 150,000 -190,000 | -56% | -$24.4M |
|
18
Brookdale Senior Living
BKD
$1.83B
| $17.7M | 2.36% | 4,183,353 +1,483,353 | +55% | +$6.26M |
|
19
Transmedics
TMDX
$3.92B
| $15.1M | 2.02% | +180,000 | New | +$15.1M |
|
|
SWTX
20
DELISTED
SpringWorks Therapeutics
SWTX
| $12.2M | 1.63% | 464,935 +152,271 | +49% | +$3.99M |
|
21
908 Devices
MASS
$226M
| $6.17M | 0.83% | 900,000 -150,000 | -14% | -$1.03M |
|
|
OLK
22
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $5.9M | 0.79% | 314,795 -85,205 | -21% | -$1.6M |
|
|
23
Charles River Laboratories
CRL
$8.04B
| – | – | -130,000 | Closed | -$26.2M |
|
|
24
Evolent Health
EVH
$1.12B
| – | – | -1,000,402 | Closed | -$32.5M |
|
|
25
Gilead Sciences
GILD
$140B
| – | – | -420,000 | Closed | -$34.8M |
|